相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
Yuxi Wang et al.
FEBS JOURNAL (2016)
Comprehensive characterization of the Published Kinase Inhibitor Set
Jonathan M. Elkins et al.
NATURE BIOTECHNOLOGY (2016)
CRISPR-Cas9-based target validation for p53-reactivating model compounds
Ichael Wanzel et al.
NATURE CHEMICAL BIOLOGY (2016)
Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Matthew G. Rees et al.
NATURE CHEMICAL BIOLOGY (2016)
Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
Susan Klaeger et al.
ACS CHEMICAL BIOLOGY (2016)
Validation and development of MTH1 inhibitors for treatment of cancer
U. Warpman Berglund et al.
ANNALS OF ONCOLOGY (2016)
Identification of potent and selective MTH1 inhibitors
Alessia Petrocchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
Sai Krishna Athuluri-Divakar et al.
CELL (2016)
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
Peng Wu et al.
DRUG DISCOVERY TODAY (2016)
Discovery of 1-{(3R,4R)-3[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
Hengmiao Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival
Jason G. Kettle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
Jonathan B. Baell
JOURNAL OF NATURAL PRODUCTS (2016)
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
Gabriela Brumatti et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
Feimeng Zheng et al.
NATURE COMMUNICATIONS (2016)
Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival
Tatsuro Kawamura et al.
SCIENTIFIC REPORTS (2016)
Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization
Kenji Tanabe
SCIENTIFIC REPORTS (2016)
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A
Jennifer Chu et al.
CELL REPORTS (2016)
Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2
Matej Janecek et al.
SCIENTIFIC REPORTS (2016)
Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection
Elzbieta Janda et al.
AUTOPHAGY (2015)
The problem of pyridinyl imidazole class inhibitors of MAPK14/p38α and MAPK11/p38β in autophagy research
Manoj B. Menon et al.
AUTOPHAGY (2015)
Going for broke: targeting the human cancer pseudokinome
Fiona P. Bailey et al.
BIOCHEMICAL JOURNAL (2015)
Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
Elias E. Stratikopoulos et al.
CANCER CELL (2015)
A Kinase-Independent Role for EGF Receptor in Autophagy Initiation
Xiaojun Tan et al.
CELL (2015)
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes
Stuart L. Schreiber et al.
CELL (2015)
Activity-Based Protein Profiling: Recent Advances in Probe Development and Applications
Pengyu Yang et al.
CHEMBIOCHEM (2015)
Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing
Jasper E. Neggers et al.
CHEMISTRY & BIOLOGY (2015)
Extending kinome coverage by analysis of kinase inhibitor broad profiling data
Edgar Jacoby et al.
DRUG DISCOVERY TODAY (2015)
Methyl 3-((6-Methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate (GN39482) as a Tubulin Polymerization Inhibitor Identified by MorphoBase and ChemProteoBase Profiling Methods
Hidemitsu Minegishi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity
Davide Carta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus
Federico Cappuzzo et al.
LUNG CANCER (2015)
Know your target, know your molecule
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2015)
The promise and peril of chemical probes
Cheryl H. Arrowsmith et al.
NATURE CHEMICAL BIOLOGY (2015)
The diverse role of RIP kinases in necroptosis and inflammation
John Silke et al.
NATURE IMMUNOLOGY (2015)
Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling
Kilian V. M. Huber et al.
NATURE METHODS (2015)
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
Friedrich B. M. Reinhard et al.
NATURE METHODS (2015)
Tackling reproducibility in academic preclinical drug discovery
Stephen V. Frye et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
Ramzi Abbassi et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Beating the odds: BETs in disease
Chen-Yi Wang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
RIPK1 and RIPK3: critical regulators of inflammation and cell death
Kim Newton
TRENDS IN CELL BIOLOGY (2015)
Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
S. Mahale et al.
CELL DEATH & DISEASE (2015)
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
Sunil J. Advani et al.
NATURE COMMUNICATIONS (2015)
Fluid shear triggers microvilli formation via mechanosensitive activation of TRPV6
Shigenori Miura et al.
NATURE COMMUNICATIONS (2015)
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
Brinton Seashore-Ludlow et al.
CANCER DISCOVERY (2015)
Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays
Ban Xiong Tan et al.
SCIENTIFIC REPORTS (2015)
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
Timothy J. Stuhlmiller et al.
CELL REPORTS (2015)
Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2
F. M. S. Gurgis et al.
CELL DEATH DISCOVERY (2015)
The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
Antje Dittmann et al.
ACS CHEMICAL BIOLOGY (2014)
Comparison of Cancer Cell Survival Triggered by Microtubule Damage after Turning Dyrk1B Kinase On and Off
Liwen Li et al.
ACS CHEMICAL BIOLOGY (2014)
ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling
Atli Thorarensen et al.
ACS CHEMICAL BIOLOGY (2014)
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
Stuart W. J. Ember et al.
ACS CHEMICAL BIOLOGY (2014)
MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation
Enrico Desideri et al.
AUTOPHAGY (2014)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Chemical biology approaches to target validation in cancer
Julian Blagg et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo
Apostolos Polykratis et al.
JOURNAL OF IMMUNOLOGY (2014)
Discovery of Biarylaminoquinazolines as Novel Tubulin Polymerization Inhibitors
Giovanni Marzaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Tivantinib (ARQ 197) Exhibits Antitumor Activity by Directly Interacting with Tubulin and Overcomes ABC Transporter-Mediated Drug Resistance
Aki Aoyama et al.
MOLECULAR CANCER THERAPEUTICS (2014)
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Pratyusha Mandal et al.
MOLECULAR CELL (2014)
BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms
B. S. Wyspianska et al.
LEUKEMIA (2014)
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
Kilian V. M. Huber et al.
NATURE (2014)
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Helge Gad et al.
NATURE (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
Marius Dannappel et al.
NATURE (2014)
DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells
Yegor Smurnyy et al.
NATURE CHEMICAL BIOLOGY (2014)
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri et al.
NATURE CHEMICAL BIOLOGY (2014)
DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets
Corynn Kasap et al.
NATURE CHEMICAL BIOLOGY (2014)
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Bryan R. Lannine et al.
NATURE CHEMICAL BIOLOGY (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
Phillip A. Schwartz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1
T. Justin Rettenmaier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death
Joanne M. Hildebrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
Kim Newton et al.
SCIENCE (2014)
A kinase-independent function of AKT promotes cancer cell survival
Igor Vivanco et al.
ELIFE (2014)
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Scott J. Dixon et al.
ELIFE (2014)
Microtubules and their role in cellular stress in cancer
Amelia L. Parker et al.
FRONTIERS IN ONCOLOGY (2014)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2013)
Dawn of the dead: protein pseudokinases signal new adventures in cell biology
Patrick A. Eyers et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
Ryohei Katayama et al.
CANCER RESEARCH (2013)
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
Amrita Basu et al.
CELL (2013)
Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET
Cristina Basilico et al.
CLINICAL CANCER RESEARCH (2013)
NRH:Quinone Oxidoreductase 2 (NQO2) Protein Competes with the 20 S Proteasome to Stabilize Transcription Factor CCAAT Enhancer-binding Protein α (C/EBPα), Leading to Protection against γ Radiation-induced Myeloproliferative Disease
Junkang Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Selective 3-Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1
Jesus R. Medina
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis
Erik C. Hett et al.
NATURE CHEMICAL BIOLOGY (2013)
Target identification and mechanism of action in chemical biology and drug discovery
Monica Schenone et al.
NATURE CHEMICAL BIOLOGY (2013)
Target validation using chemical probes
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Small molecule sensitization to TRAIL is mediated via nuclear localization, phosphorylation and inhibition of chaperone activity of Hsp27
G. Mellier et al.
CELL DEATH & DISEASE (2013)
Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK
Haitao Zhang et al.
APOPTOSIS (2012)
MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy
Salome Paillas et al.
AUTOPHAGY (2012)
Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors
Ayaz Najafov et al.
BIOCHEMICAL JOURNAL (2012)
The Kynurenine Pathway in Brain Tumor Pathogenesis
Seray Adams et al.
CANCER RESEARCH (2012)
Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site
Katrien Busschots et al.
CHEMISTRY & BIOLOGY (2012)
Indoleamine 2,3-dioxygenase: From catalyst to signaling function
Francesca Fallarino et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Chemistry-based functional proteomics for drug target deconvolution
Kui Wang et al.
EXPERT REVIEW OF PROTEOMICS (2012)
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Tjeerd Barf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Using transcriptome sequencing to identify mechanisms of drug action and resistance
Sarah A. Wacker et al.
NATURE CHEMICAL BIOLOGY (2012)
Study finds a potential new way to target and destroy proliferating tumors
Claire Attwood
THERAPEUTIC DELIVERY (2012)
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Joanne Bowes et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance
M. A. de la Cruz-Morcillo et al.
ONCOGENE (2012)
Kinase-independent function of checkpoint kinase 1 (Chk1) in the replication of damaged DNA
Juliana Speroni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
Ballachanda N. Devaiah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
N. Takahashi et al.
CELL DEATH & DISEASE (2012)
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
Arvin C. Dar et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
Katharine Ellwood-Yen et al.
CANCER RESEARCH (2011)
The secret life of kinases: functions beyond catalysis
Jens Rauch et al.
CELL COMMUNICATION AND SIGNALING (2011)
High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors
Chandrasekhar V. Miduturu et al.
CHEMISTRY & BIOLOGY (2011)
Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197
Sudharshan Eathiraj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
OPINION Mitosis is not a key target of microtubule agents in patient tumors
Edina Komlodi-Pasztor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation
J. K. Cheong et al.
ONCOGENE (2011)
SB202190-Induced Cell Type-Specific Vacuole Formation and Defective Autophagy Do Not Depend on p38 MAP Kinase Inhibition
Manoj B. Menon et al.
PLOS ONE (2011)
A MEK-independent role for CRAF in mitosis and tumor progression
Ainhoa Mielgo et al.
NATURE MEDICINE (2011)
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+myeloma cells
Vijay Ramakrishnan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Fluorescence polarization binding assay to develop inhibitors of inactive p38α mitogen-activated protein kinase
Lenka Munoz et al.
ANALYTICAL BIOCHEMISTRY (2010)
EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity
Hu Zhu et al.
CANCER LETTERS (2010)
Application of Proteomic Profiling Based on 2D-DIGE for Classification of Compounds According to the Mechanism of Action
Makoto Muroi et al.
CHEMISTRY & BIOLOGY (2010)
Coordinated regulation of autophagy by p38α MAPK through mAtg9 and p38IP
Jemma L. Webber et al.
EMBO JOURNAL (2010)
Enhanced Indoleamine 2,3-Dioxygenase Activity in Patients with Severe Sepsis and Septic Shock
Pierre Tattevin et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation
Robert J. Mourey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
Neru Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
David Parry et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity
Byron B. Au-Yeung et al.
NATURE IMMUNOLOGY (2010)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Activity-based protein profiling for biochemical pathway discovery in cancer
Daniel K. Nomura et al.
NATURE REVIEWS CANCER (2010)
LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide-Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors
Kirthan Shenoy et al.
CANCER RESEARCH (2009)
Blockade of Indoleamine 2,3-Dioxygenase Protects Mice against Lipopolysaccharide-Induced Endotoxin Shock
In Duk Jung et al.
JOURNAL OF IMMUNOLOGY (2009)
Selective Inhibition of Casein Kinase 1ε Minimally Alters Circadian Clock Period
Kevin M. Walton et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Erythropoietic protoporphyria
Mario Lecha et al.
ORPHANET JOURNAL OF RARE DISEASES (2009)
The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
Jonathan A. Winger et al.
BMC STRUCTURAL BIOLOGY (2009)
Survival of cancer cells is maintained by EGFR independent of its kinase activity
Zhang Weihua et al.
CANCER CELL (2008)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo
C. Brockschmidt et al.
GUT (2008)
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
Petra Ross-Macdonald et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Identification of RIP1 kinase as a specific cellular target of necrostatins
Alexei Degterev et al.
NATURE CHEMICAL BIOLOGY (2008)
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Oleg Fedorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations
A. Pardanani et al.
LEUKEMIA (2007)
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)
David R. Anderson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1
Alireza S. Alavi et al.
CANCER RESEARCH (2007)
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
Martin Steegmaier et al.
CURRENT BIOLOGY (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-akt pathway.
TW Poh et al.
CANCER RESEARCH (2005)
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
A Degterev et al.
NATURE CHEMICAL BIOLOGY (2005)
Features of selective kinase inhibitors
ZA Knight et al.
CHEMISTRY & BIOLOGY (2005)
Discovery and characterization of a substrate selective p38α inhibitor
W Davidson et al.
BIOCHEMISTRY (2004)
Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis
K Iskander et al.
CANCER RESEARCH (2004)
Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity
S Middendorp et al.
JOURNAL OF IMMUNOLOGY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity
DJ Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects
L Behrend et al.
ONCOGENE (2000)
Crystal structure of a conformation-selective casein kinase-1 inhibitor
N Mashhoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
